- AT&T Announces Nearly 60 Jobs Available in Huntington
- NNSA releases Environmental Review of UPF Bomb Plant Plans
- Pike County Murder Investigation: Update
- School of Physical Therapy cloaks students during White Coat Ceremony
- Congressman Shuster Endorses Donald Trump for President
- Marshall University Forensic Science Graduate Program student receives national award
- Clinton Discussing Substance Abuse, Addiction at Charleston Briefing
- May 7 th 2016 is Free Comic Book Day at Comic World
- WV Film Office Announces New Casting Calls
- Portsmouth Waste Reburial: "Classification" withholds truths for that which is not actually classified
School of Pharmacy faculty publish in peer-reviewed journal
The team recently published a commentary on the importance of defining the term "polypharmacy," which according to the authors has at least 24 distinct meanings and should be more narrowly defined to reduce confusion in research as well as education.
Faculty members Chris Gillette, Ph.D., Leesa Prunty, Pharm.D., Janet Wolcott, Pharm.D., and Kimberly Broedel-Zaugg, R.Ph., M.B.A., Ph.D., contributed to the manuscript, which was published in late August in the journal "Research in Social and Administrative Pharmacy."
Gillette says the need to redefine the term polypharmacy is ultimately a drug safety issue.
"The goal of our paper is meant to start a dialogue within the health services research community that ultimately means better health care for patients," he said. "We propose the term be defined as patients going to more than one pharmacy for their prescriptions."
The team also proffered a new term, "extraordinary prescribing," to define patients who are taking medications that are either grossly excessive or not beneficial for those patients.In its manuscript, the Marshall team acknowledged that neither of the current terms in the new lexicon is perfect in description, but if accepted by the research and education community should reduce confusion.